Klotho Neurosciences, Inc. - Common Stock

Share · US49876K1034 · KLTO (XNAS)

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of Klotho Neurosciences, Inc. - Common Stock

No Price

28.04.2026 23:56

Current Prices from Klotho Neurosciences, Inc. - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	GRML	USD	28.04.2026 23:56	0,44 USD	-0,03 USD -5,68 %
IEX	GRML	USD	28.04.2026 19:55	0,44 USD	-0,02 USD -4,58 %

Share Float & Liquidity

Free Float 84,83 %

Shares Float 61,49 M

Shares Outstanding 72,49 M

Company Profile for Klotho Neurosciences, Inc. - Common Stock Share

Klotho Neurosciences, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates include AMI-101 for the treatment or prevention of Alzheimer's disease; and AMI-202 to treat and prevent amyotrophic lateral sclerosis. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. The company is based in Omaha, Nebraska.